Inicio > BIGG > Resultado de la búsqueda

    Resultados: 3

    Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline

    Stuenkel, C. A; Davis, S. R; Gompel, A; Lumsden, M. A; Murad, M. H; Pinkerton, J. V; Santen, R. J.
    J. clin. endocrinol. metab; 100 (11), 2015
    OBJECTIVE: The objective of this document is to generate a practice guideline for the management and treatment of symptoms of the menopause. PARTICIPANTS: The Treatment of Symptoms of the Menopause Task Force included six experts, a methodologist, and a medical writer, all appointed by The Endocrine Soci...
    Menopausia, Terapia de Reemplazo de Estrógeno, Climaterio, Factores de Riesgo, Enfermedades Cardiovasculares/prevención & control, Neoplasias de la Mama/prevención & control, Enfermedades Urogenitales Femeninas/prevención & control, Sofocos/tratamiento farmacológico, Enfoque GRADE
    Texto completo

    Treatment of cushing's syndrome: an Endocrine Society Clinical Practice Guideline

    Nieman, L. K; Biller, B. M; Findling, J. W; Murad, M. H; Newell-Price, J; Savage, M. O; Tabarin, A.
    J. clin. endocrinol. metab; 100 (8), 2015
    OBJECTIVE: The objective is to formulate clinical practice guidelines for treating Cushing's syndrome. PARTICIPANTS: Participants include an Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. The European Society for Endocrinology co-sponsored the guideline. EVIDENC...
    Síndrome de Cushing/terapia, Recurrencia, Adrenalectomía, Antihipertensivos/uso terapéutico, Planificación de Atención al Paciente, Inducción de Remisión
    Texto completo

    Pharmacological management of obesity: an Endocrine Society clinical practice guideline

    Apovian, C. M; Aronne, L. J; Bessesen, D. H; McDonnell, M. E; Murad, M. H; Pagotto, U; Ryan, D. H; Still, C. D.
    J. clin. endocrinol. metab; 100 (2), 2015
    OBJECTIVE: To formulate clinical practice guidelines for the pharmacological management of obesity. PARTICIPANTS: An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. This guideline was co-sponsored by the European Society of Endocrinology and The Obesity Society. ...
    Obesidad/tratamiento farmacológico, Diabetes Mellitus/etiología, Depresión/etiología, Serotoninérgicos/uso terapéutico, Dopaminérgicos/uso terapéutico, Norepinefrina/uso terapéutico, Fentermina/uso terapéutico, Bupropión/uso terapéutico, Naltrexona/uso terapéutico, Péptido 1 Similar al Glucagón/agonistas
    Texto completo